PTGS1 and ulcer disease: NSAID-induced ulcers typically result from the inhibition of Cyclooxygenase 1 and 2 enzymes, which reduces protective prostaglandins in the gastric mucosa, necessitating strategies that focus on more potent acid suppression and mucosal protection.